Organisation
PROBE’s governance ensures transparent, collaborative decision-making across its 39 partners, with Steering and Executive Committees overseeing strategic direction, Work Package Leaders driving execution, and Stakeholder Councils and the Scientific Advisory Board safeguarding compliance, patient-centricity, and ensuring uptake of project outputs.
The General Assembly is the governing body including representatives of all thirty-nine (39) partners.
Project Management office – The Project Management Office (PMO) is coordinating all project management aspects, supporting the project overall.
The Project Management Office (PMO) is coordinating all project management aspects, supporting the project overall.
The Health Care Providers Council (HCPC), through the inclusion of representatives from European healthcare professional networks and organisations, this external council will advise PROBE and ensure connection with and the integration of HCP voices across PROBE activities.
The external, advisory role of the Regulatory & HTA Council (RHTAC) is to facilitate engagement with regulatory agencies (EMA + FDA) and HTA bodies to implement advice, provide opportunities for synergy, and align project efforts with the rules and frameworks for the approval of novel endpoints.
